Thereâs been a lot of blogging about vaccines lately:
-
Mark Meier at Science Progress explains how a cocaine-addiction vaccine was developed, and what questions and hurdles it still faces.
-
Jacob Goldstein at WSJâs Health Blog explains what this yearâs mismatched flu vaccine means for next yearâs production (also see Effect Measure on this yearâs flu season).
-
DrugMonkey and Mike Dunford at the Questionable Authority are livid about the parents whose antivaccination stance led to measles for their three children and several others.
-
Abel Pharmboy at Terra Sigillata focuses on the dangerous antivaccinationist movement and what American Association of Pediatrics is doing to combat it (although itâs his vasectomy liveblogging thatâs drawing most of his visitors).
Elsewhere:
Emily Monosson at The Neighborhood Toxicologist investigates EPAâs decisions about nanotechnology regulation.
David Roberts at Gristmill looks at the big stories emerging from the League of Conservation Votersâ just-released scorecard.
Roy M. Poses MD at Health Care Renewal delves into the torturous supply chain and inadequate oversight of Baxterâs heparin.
Maggie Mahar at Health Beat wonders where the doctors were during the âCholesterol Conâ thatâs now coming to light.
Merrill Goozner at GoozNews suggests a different approach that FDA could use regarding the approval of Avastin for breast cancer.
Lisa Codipoti at Womenstake uses a personal example to illustrate one of the problems with primary care in our current system.
Michael Kremer at Global Health Policy explains why mass treatment through schools is an effective use of the funds President Bush has pledged to invest in fighting neglected tropical diseases.
- Log in to post comments
Thanks, Liz! I'm never one to pass up a personal event as a learning opportunity for promoting public health and medical education!
Great post, and I think the Chinese will do nothing that sounds remotely threatening to the Western companies producing drugs/food in China. And the FDA will continue to merely issue warnings and do nothing. Hard to be optimistic when your president is so partial to industry and indifferent to consumers.